Operators are excited about a device that avoids transapical access, a limitation of other systems, says Gilbert Tang.
Five-year data from the PARTNER 3 trial showed that among low-risk patients with severe, symptomatic aortic stenosis, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback